Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Year: 2007
Type: review
Source: Neurology
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, disease-modifying therapy, mild cognitive impairment, primary prevention, clinical trial design, biomarkers, amyloid imaging, medial temporal lobe atrophy, FDG-PET hypometabolism, amyloid-beta, tau protein, cerebrospinal fluid biomarkers, trial enrichment, presymptomatic detection, neuropsychological assessment, ADAPT trial, glycogen synthase kinase, peroxisome proliferator-activated receptors
Open Access status: closed
Funder: National Institute on Aging
OpenAlex ID: W2015514982
